APA

Kiga M., Tanzawa F., Iwasaki S., Inaba F., Fujiwara K., Iwadare H., Echigo T., Nakamura Y., Shibata T., Suzuki K., Yasumatsu I., Nakayama A., Sasazawa Y., Tashiro E., Imoto M. & Kurakata S. (20120618). Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17. : Anti-cancer drugs.

Chicago

Kiga Masaki, Tanzawa Fumie, Iwasaki Shiho, Inaba Fumi, Fujiwara Kosaku, Iwadare Hayato, Echigo Tomoki, Nakamura Yuji, Shibata Tomoyuki, Suzuki Kanae, Yasumatsu Isao, Nakayama Ayako, Sasazawa Yukiko, Tashiro Etsu, Imoto Masaya and Kurakata Shinichi. 20120618. Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17. : Anti-cancer drugs.

Harvard

Kiga M., Tanzawa F., Iwasaki S., Inaba F., Fujiwara K., Iwadare H., Echigo T., Nakamura Y., Shibata T., Suzuki K., Yasumatsu I., Nakayama A., Sasazawa Y., Tashiro E., Imoto M. and Kurakata S. (20120618). Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17. : Anti-cancer drugs.

MLA

Kiga Masaki, Tanzawa Fumie, Iwasaki Shiho, Inaba Fumi, Fujiwara Kosaku, Iwadare Hayato, Echigo Tomoki, Nakamura Yuji, Shibata Tomoyuki, Suzuki Kanae, Yasumatsu Isao, Nakayama Ayako, Sasazawa Yukiko, Tashiro Etsu, Imoto Masaya and Kurakata Shinichi. Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17. : Anti-cancer drugs. 20120618.